Matin

Canadian Safety Professionals Honour Avetta for Excellence in Technology to Protect Workers

Retrieved on: 
Monday, November 27, 2023

They also determined the best technology for lone workers and employees dealing with impairment and fatigue.

Key Points: 
  • They also determined the best technology for lone workers and employees dealing with impairment and fatigue.
  • “Avetta has always placed safety first,” said Arshad Matin, Avetta CEO.
  • Avetta continues to invest and grow in Canada, expanding to a supplier base of about 30,000 contractor and supplier companies.
  • For a list of all Canadian Occupational Safety winners, go to www.thesafetymag.com/ca .

CORDIS NAMES BRYAN LOO PRESIDENT OF ASIA-PACIFIC REGION

Retrieved on: 
Friday, July 8, 2022

MIAMI LAKES, Fla., July 8, 2022 /PRNewswire/ -- Cordis, a global leader in cardiovascular technologies, today announced that Bryan Loo will assume the role of President of the Asia-Pacific (APAC) region effective July 18, 2022. Loo will head a leadership team responsible for commercial and clinical strategy, business operations, and teammate development in the company's fast-growing APAC region.

Key Points: 
  • MIAMI LAKES, Fla., July 8, 2022 /PRNewswire/ --Cordis, a global leader in cardiovascular technologies, today announced that Bryan Loo will assume the role of President of the Asia-Pacific (APAC) region effective July 18, 2022.
  • Loo will head a leadership team responsible for commercial and clinical strategy, business operations, and teammate development in the company's fast-growing APAC region.
  • "We are pleased to welcome Bryan to the team," said Cordis CEO Shar Matin.
  • Loo joins Cordis from Genesis Medtech, where he served as President and built the infrastructure for its vertically integrated, open-platform model.

Cordis Makes Strategic Investment in E2, a developer of Next-Generation Thrombectomy Devices

Retrieved on: 
Tuesday, April 5, 2022

MIAMI LAKES, Fla., April 5, 2022 /PRNewswire/ -- Cordis today announced a strategic investment venture that will expand the scope of the global cardiovascular technology company into the Venous Thromboembolism Market (VTM) with a strategic investment in Endovascular Engineering ("E2"), a developer of next-generation thrombectomy devices to treat patients with Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE). 

Key Points: 
  • "Our investment in E2 positions Cordis at the vanguard of innovation in venous interventions," said Duke Rohlen, Executive Chairman of Cordis and CEO of Cordis-X, an independent accelerator created to drive innovation and growth for Cordis.
  • "We are proud to support the team's efforts to define a new standard of care for patients suffering from thromboembolism."
  • Cordis is partnering with SantVentures and another strategic investor in the E2 transaction.
  • The investment in E2 supports Cordis' legacy as a leader in creating lifesaving cardiovascular technologies."

New Avetta One™ Platform Provides Unified View of Supply Chain Risk for Companies and Their Suppliers

Retrieved on: 
Wednesday, January 19, 2022

Avetta One delivers a global platform that manages critical risk areas in supply chains, creating the industrys largest and most comprehensive supply chain risk management platform.

Key Points: 
  • Avetta One delivers a global platform that manages critical risk areas in supply chains, creating the industrys largest and most comprehensive supply chain risk management platform.
  • Avetta One will give Avetta clients an unprecedented view of their supply chain risk programs through multi-risk analytics, supplier risk trends and supplier performance benchmarking.
  • Avetta One helps companies focus on leading indicators that help companies proactively manage risks through a holistic view of the entire supply chain.
  • The Avetta SaaS platform helps clients manage supply chain risk and their suppliers to become more qualified for jobs.

Cordis Names Muscari President Of The Americas

Retrieved on: 
Tuesday, November 2, 2021

MIAMI LAKES, Fla., Nov. 2, 2021 /PRNewswire/ --Cordis, a global interventional vascular technology company, today announced that Matthew Muscari will assume the role of President of the Americas, heading a leadership team responsible for commercial operations, including global and regional marketing, sales, and sales operations for the Americas.

Key Points: 
  • MIAMI LAKES, Fla., Nov. 2, 2021 /PRNewswire/ --Cordis, a global interventional vascular technology company, today announced that Matthew Muscari will assume the role of President of the Americas, heading a leadership team responsible for commercial operations, including global and regional marketing, sales, and sales operations for the Americas.
  • Muscari directed CSI's growth of the U.S. Office Based Lab (OBL) channel to constitute 50% of the business.
  • "I am thrilled and honored to join the Cordis team," said Muscari.
  • According to Matin, Muscari was instrumental in implementing a full cultural transformation at CSI, something that Cordis seeks to accomplish as a fundamental pillar of its future growth.

ViewRay Announces Departure of Chief Operating Officer

Retrieved on: 
Monday, March 15, 2021

CLEVELAND, March 15, 2021 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) ("the Company") today announced that Shahriar Matin, Chief Operating Officer, will leave the Company effective March 31, 2021.

Key Points: 
  • CLEVELAND, March 15, 2021 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) ("the Company") today announced that Shahriar Matin, Chief Operating Officer, will leave the Company effective March 31, 2021.
  • Matin was named Chief Executive Officer designate of Cordis in its recently announced divestiture from Cardinal Health to private equity firm Hellman & Friedman.
  • "It has been a privilege to work alongside the ViewRay team, and I believe that MRIdian is unequivocally the future of radiation oncology," said Shahriar Matin, Chief Operating Officer.
  • I wish him continued success and hearty congratulations in his new endeavors," said President and Chief Executive Officer Scott Drake.

Avetta Names Arshad Matin Its New President and Chief Executive to Drive Next Stage of Growth

Retrieved on: 
Monday, October 21, 2019

Mr. Matin succeeds John Herr, who is stepping down as Chief Executive Officer.

Key Points: 
  • Mr. Matin succeeds John Herr, who is stepping down as Chief Executive Officer.
  • View the full release here: https://www.businesswire.com/news/home/20191021005717/en/
    Arshad Matin is President and Chief Executive Officer of Avetta (Photo: Business Wire)
    Mr. Matin brings to Avetta deep experience in successfully leading high-technology and software companies over the past 25 years.
  • Recently, he served as President, Chief Executive Officer and Board member of Paradigm Ltd., a leading developer of software solutions to the global oil and gas industry.
  • At Avetta, Mr. Matin will be responsible for advancing the Companys next stage of growth.